RU95100770A - ANTI-INFLAMMATORY COMPOSITIONS OF LOCAL USE CONTAINING PYROXYKS, METHOD OF SOLUBILIZING PYROXYCAM - Google Patents

ANTI-INFLAMMATORY COMPOSITIONS OF LOCAL USE CONTAINING PYROXYKS, METHOD OF SOLUBILIZING PYROXYCAM

Info

Publication number
RU95100770A
RU95100770A RU95100770/14A RU95100770A RU95100770A RU 95100770 A RU95100770 A RU 95100770A RU 95100770/14 A RU95100770/14 A RU 95100770/14A RU 95100770 A RU95100770 A RU 95100770A RU 95100770 A RU95100770 A RU 95100770A
Authority
RU
Russia
Prior art keywords
amount
composition
composition according
piroxicam
present
Prior art date
Application number
RU95100770/14A
Other languages
Russian (ru)
Other versions
RU2138266C1 (en
Inventor
Тек Шин Чунг
Босюий Люк
Original Assignee
Бристоль-Мейерз Сквибб Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/181,510 external-priority patent/US5436241A/en
Application filed by Бристоль-Мейерз Сквибб Компани filed Critical Бристоль-Мейерз Сквибб Компани
Publication of RU95100770A publication Critical patent/RU95100770A/en
Application granted granted Critical
Publication of RU2138266C1 publication Critical patent/RU2138266C1/en

Links

Claims (18)

1. Композиция, включающая: (i) противовоспалительно-эффективное количество пироксикама; (ii) количество тетрагидроксипропил этилендиамина, достаточное для солюбилизации пироксикама в композиции; (iii) количество С2 - С6-алкилен гликоля или их смесей, достаточное для предотвращения липкости композиции и обеспечения ее увлажнения: (iv) приблизительно от 0,2 до 2% карбомера; (v) приблизительно от 30 до 60% С2-4 алканола: и (vi) воду для доведения композиции до 100%.1. A composition comprising: (i) an anti-inflammatory effective amount of piroxicam; (ii) an amount of tetrahydroxypropyl ethylenediamine sufficient to solubilize piroxicam in the composition; (iii) an amount of C 2 -C 6 alkylene glycol or mixtures thereof sufficient to prevent the composition from sticking and to provide moisture: (iv) from about 0.2 to 2% carbomer; (v) from about 30 to 60% C 2-4 alkanol: and (vi) water to bring the composition to 100%. 2. Композиция по п. 1, включающая дополнительно приблизительно от 0,25 до 1% гидроксипропил целлюлозы. 2. The composition of claim 1, further comprising from about 0.25 to 1% hydroxypropyl cellulose. 3. Композиция по п. 2, в которой гидроксипропил целлюлоза присутствует в количестве приблизительно от 0,5 до 0,75%. 3. The composition according to claim 2, in which hydroxypropyl cellulose is present in an amount of from about 0.5 to 0.75%. 4. Композиция по п. 1, в которой алканол присутствует в количестве приблизительно от 35 до 55%. 4. The composition of claim 1, wherein the alkanol is present in an amount of from about 35 to 55%. 5. Композиция по п. 1, в которой С2 - С6 алкилен гликолем является пропилен гликоль, бутилен гликоль, гексилен гликоль, дипропилен гликоль, глицерин или их смесь.5. The composition of claim 1, wherein the C 2 -C 6 alkylene glycol is propylene glycol, butylene glycol, hexylene glycol, dipropylene glycol, glycerin, or a mixture thereof. 6. Композиция по п. 5. в которой смесь представляет собой пропилен гликоль, дипропилен гликоль и глицерин в соотношении соответственно 3:2:2.5. 6. The composition according to p. 5. in which the mixture is propylene glycol, dipropylene glycol and glycerin in a ratio of 3: 2: 2.5, respectively. 7. Композиция по п. 1, в которой алкилен гликоль присутствует в количестве приблизительно от 5 до 20%. 7. The composition according to p. 1, in which alkylene glycol is present in an amount of from about 5 to 20%. 8. Композиция по п. 7, в которой алкилен гликоль присутствует в количестве приблизительно от 10 до 15%. 8. The composition according to p. 7, in which alkylene glycol is present in an amount of from about 10 to 15%. 9. Композиция по п. 1, в которой карбомер присутствует в количестве приблизительно от 0,5 до 1,5%. 9. The composition of claim 1, wherein the carbomer is present in an amount of about 0.5 to 1.5%. 10. Композиция по п. 1, в которой карбомер представляет собой Карбомер 940 или Карбомер 980. 10. The composition according to claim 1, in which the carbomer is a carbomer 940 or carbomer 980. 11. Композиция по п. 1, дополнительно включающая противораздражающее средство выбранное из группы, состоящей из ментола, эвгенола, метил салицилата, камфоры и их смесей. 11. The composition according to claim 1, further comprising an anti-irritant selected from the group consisting of menthol, eugenol, methyl salicylate, camphor, and mixtures thereof. 12. Композиция по п. 1, представляющая прозрачный гель. 12. The composition according to p. 1, representing a transparent gel. 13. Композиция, включающая пироксикам и количество тетрагидроксипропил этилендиамина, достаточное для солюбилизации пироксикама. 13. A composition comprising piroxicam and an amount of tetrahydroxypropyl ethylenediamine sufficient to solubilize piroxicam. 14. Способ солюбилизации пироксикама, включающий смешение пироксикама о количеством тетрагидроксипропил этилендиамина, достаточным для солюбилизации пироксикама. 14. A method of solubilizing piroxicam, comprising mixing piroxicam about the amount of tetrahydroxypropyl ethylenediamine sufficient to solubilize piroxicam. 15. Композиция по п. 1, в которой пироксикам присутствует в количестве приблизительно от 0,3 до 2%. 15. The composition according to p. 1, in which piroxicam is present in an amount of from about 0.3 to 2%. 16. Композиция по п. 1, в которой пироксикам присутствует в количестве приблизительно от 0,75 до 1,5%. 16. The composition according to claim 1, in which piroxicam is present in an amount of from about 0.75 to 1.5%. 17. Композиция по п. 1, в которой тетрагидроксипропил этилендиамин присутствует в количестве приблизительно 2 до 4%. 17. The composition according to claim 1, in which tetrahydroxypropyl ethylenediamine is present in an amount of about 2 to 4%. 18. Композиция по п. 1, в которой тетрагидроксипропил этилендиамин присутствует в количестве приблизительно от 2,5 до 3,5%. 18. The composition according to claim 1, in which tetrahydroxypropyl ethylenediamine is present in an amount of from about 2.5 to 3.5%.
RU95100770/14A 1994-01-14 1995-01-13 Piroxicam-containing anti-inflammatory compositions for topical use, method of solubilization of piroxicam RU2138266C1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/181,510 US5436241A (en) 1994-01-14 1994-01-14 Topical anti-inflammatory compositions containing piroxicam
US08/181,510 1994-01-14

Publications (2)

Publication Number Publication Date
RU95100770A true RU95100770A (en) 1997-11-27
RU2138266C1 RU2138266C1 (en) 1999-09-27

Family

ID=22664576

Family Applications (1)

Application Number Title Priority Date Filing Date
RU95100770/14A RU2138266C1 (en) 1994-01-14 1995-01-13 Piroxicam-containing anti-inflammatory compositions for topical use, method of solubilization of piroxicam

Country Status (14)

Country Link
US (1) US5436241A (en)
JP (1) JPH07206680A (en)
CN (1) CN1088587C (en)
BG (1) BG63031B1 (en)
BR (1) BR9500206A (en)
CZ (1) CZ10295A3 (en)
GR (1) GR1002351B (en)
HU (1) HU225896B1 (en)
MY (1) MY114860A (en)
PH (1) PH31650A (en)
PL (1) PL177710B1 (en)
RU (1) RU2138266C1 (en)
TW (1) TW358027B (en)
ZA (1) ZA949250B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO379596A0 (en) 1996-11-22 1996-12-19 Soltec Research Pty Ltd Percutaneous delivery system
WO1999039713A1 (en) * 1998-02-09 1999-08-12 Chong Kun Dang Pharmaceutical Corp. Piroxicam-containing hydroalcoholic gel composition
FR2797766B1 (en) * 1999-08-27 2003-04-04 Menarini France NEW TOPICAL FORMS WITH A PASTY CONSISTENCY IN THE FORM OF A GEL DISTRIBUTED IN DOSES
JP4108271B2 (en) * 2000-12-21 2008-06-25 花王株式会社 Gel cosmetic
US20060067958A1 (en) * 2004-09-24 2006-03-30 Unilab Pharmatech, Ltd. Pharmaceutical topical gel compositions
US8221046B2 (en) 2005-02-25 2012-07-17 Johnson & Johnson Consumer Companies, Inc. Compositions containing amines and use thereof
US8278359B2 (en) * 2005-02-25 2012-10-02 Johnson & Johnson Consumer Companies, Inc. Compositions containing amines and use thereof to treat acne or reduce the appearance of oil or pores on the skin
US20060193814A1 (en) 2005-02-25 2006-08-31 Eduardo Ruvolo Compositions for the treatment of signs of aging
MX2007009796A (en) * 2007-08-14 2009-02-25 Cell Therapy And Technology S Gel containing pirfenidone.
US20090227683A1 (en) * 2008-03-06 2009-09-10 Liebel Frank T Compositions for Providing an Analgesic Effect to the Skin
CA2719512A1 (en) 2010-11-01 2012-05-01 Stiefel Research Australia Pty Ltd Polymeric topical compositions
MX357376B (en) * 2011-06-22 2018-07-06 Laboratorios Senosiain S A De C V Star Pharmaceutical composition for use against inflammation and pain.
DE102013215828A1 (en) * 2013-08-09 2015-02-12 Beiersdorf Ag Gel-shaped sunscreen with fatty alcohols
KR102324870B1 (en) * 2014-11-13 2021-11-09 주식회사 엘지생활건강 Cosmetic composition stabilizing insoluble ingredient
US10744174B1 (en) * 2016-03-16 2020-08-18 Robert Alonso Composition(s) and method(s) for topically treating pain

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3591584A (en) * 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
JPS5913714A (en) * 1982-07-13 1984-01-24 Taito Pfizer Kk Antiphlogistic and analgesic agent for external use
LU84941A1 (en) * 1983-08-02 1985-04-24 Oreal NOVEL POLYANIONIC COMPOUNDS DERIVED FROM ARYLETHERS OF POLYGLYCEROLS
US4582831A (en) * 1984-11-16 1986-04-15 Pfizer Inc. Anti-inflammatory polymorphic monoethanolamine salt of N-(2-pyridyl)-2-methyl-4-hydroxy-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide compound, composition, and method of use therefor
KR890001236B1 (en) * 1985-10-02 1989-04-28 화이자 인코포레이티드 Process for preparing antiinflammatory compositions
US5081118A (en) * 1987-10-26 1992-01-14 Pfizer Inc. Benzothiazine dioxide derivatives
JPH0347134A (en) * 1989-03-08 1991-02-28 Hoechst Japan Ltd Production of hydrogel preparation and xerogel preparation

Similar Documents

Publication Publication Date Title
RU95100770A (en) ANTI-INFLAMMATORY COMPOSITIONS OF LOCAL USE CONTAINING PYROXYKS, METHOD OF SOLUBILIZING PYROXYCAM
ES8500738A1 (en) Topical anti-inflammatory compositions.
DE69414840D1 (en) ACCEPTABLE PHARMACEUTICAL COMPOSITION CONTAINING AN ALCOHOL AND A HYDROPHALIC ACTIVE SUBSTANCE
ATE5125T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING SANGUINARIA AND GALANGAL FOR THE TREATMENT OF PERIODONTITIS AND TUMORS.
JPS5525430A (en) Thickening and gelling agent
PT73879B (en) 1-CARBOXYALKANOYLINDOLINE-2-CARBONIC ACIDS PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINED THESE COMPOUNDS AND THERAPEUTIC USE THEREOF
RU97112461A (en) CHALKONES AND THEIR ETHERS WITH ANTIPROLIFERATIVE ACTIVITY AGAINST TUMORS OF THE UTERUS, OVARIUM AND BREAST
FR2734481B1 (en) STABILIZED PSEUDO-EMULSIONS AND THEIR PREPARATION PROCESS
JPH07206680A (en) Local anti-inflammatory composition containing piroxicam
AR012546A1 (en) USE OF AT LEAST ONE SELECTED COMPOUND BETWEEN THE GROUP COMPRISING THE SOGAOLS AND THE GINGEROLES FOR THE PREPARATION OF A COMPOSITION DEODORANTE, SOGAOL, GROSS EXTRACT AND PURIFIED EXTRACT CONTAINING THE SOGAOL AND THE DEODANT COMPOSITION.
DE69531736D1 (en) MEDICINAL PRODUCT CONTAINING OXYTETRACYCLIN WITH DELAYED DELIVERY OF ACTIVE SUBSTANCE
MA22343A1 (en) MASSEPAIN COMPOSITIONS CONTAINING PSYLLIUM
JPS60228419A (en) Preventive for gingivitis
JP4101437B2 (en) Gel cosmetic
JPS57126414A (en) Ointment
JPS5750914A (en) Betamethasone external pharmaceutical
JP3119491B2 (en) Topical melanin production inhibitor
JPS57171913A (en) Base for ointment
TH17309A (en) A topical anti-inflammatory formula containing piroxicam.
ATE270095T1 (en) MEDICINAL PRODUCTS FOR USE IN THE MOUTH
IT1204778B (en) INJECTABLE PHARMACEUTICAL FORMULATIONS OF ACTIVE INGREDIENTS FOR GENERAL ANESTHETIC ACTIVITIES
TH7055B (en) A topical anti-inflammatory formula containing piroxicam.
JPS56125306A (en) Transparent cosmetic
KR920002143A (en) Process for preparing zinc carbocysteinate composition
KR970032876A (en) Pharmaceutical composition for treating liver disease